Key statistics
As of last trade, iRhythm Technologies Inc (0A7L:LSE) traded at 87.31, 55.55% above the 52 week low of 56.13 set on Oct 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 87.31 |
Low | 87.31 |
Bid | -- |
Offer | -- |
Previous close | 88.21 |
Average volume | 308.67 |
---|---|
Shares outstanding | 31.30m |
Free float | 31.02m |
P/E (TTM) | -- |
Market cap | 2.73bn USD |
EPS (TTM) | -4.85 USD |
Data delayed at least 20 minutes, as of Nov 13 2024 14:38 GMT.
More ▼
Announcements
- iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
- iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
- iRhythm Technologies Announces Third Quarter 2024 Financial Results
- Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
- iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
- iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
- iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
- iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
- iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
- iRhythm Technologies Announces Results of GUARD-AF Trial
More ▼